We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




合成 DNA / RNA 类似物显示强大的抗菌活性

By LabMedica International staff writers
Posted on 19 Nov 2013
Print article
图片:鲍氏不动杆菌的扫描电子显微镜图像,显示其基因组(外圈)和异型岛序列(内圈,红色)(照片由美国疾病控制中心的 J. Carr、以及耶鲁大学的T. Gianoulis 和 D. Massa 提供)
图片:鲍氏不动杆菌的扫描电子显微镜图像,显示其基因组(外圈)和异型岛序列(内圈,红色)(照片由美国疾病控制中心的 J. Carr、以及耶鲁大学的T. Gianoulis 和 D. Massa 提供)
肽共轭的磷酰二胺吗啉代寡核苷酸 (PPMO) 是合成的 DNR/RNA 类似物,是特定基因的静默表达,研究发现 PPMO 体外和体内均能抑制不动杆菌的生长。

俄勒冈州立大(美国俄勒冈州科瓦利斯)的研究人员试图确定 PPMO 体外和体内时是否以鲁氏不动杆菌和鲍氏不动杆菌的必需基因为靶点。他们使用药物最低抑菌浓度 (MIC) 和免疫活性评估了 PPMO 的体外培养物,并使用鼻内 PPMO 治疗的小鼠肺感染模型进行了体内评估。

研究结果已发表于 2013 年 10 月 14 日的网络版《传染病期刊》(Journal of Infectious Diseases),揭示最有效的 PPMO 检测项目为 (RXR) 4-AcpP,后者以 acpP 基因为靶点。PPMO 降低鲁氏不动杆菌和鲍氏不动杆菌的免疫活性,每毫升形成 1000 多个菌落单位,MIC 为 5-8 倍。(RXR)4-AcpP 治疗的小鼠存活时间更长,比乱序对照 PPMO 或磷酸盐缓冲盐治疗的小鼠炎症少,且细菌肺负担小。治疗可以延迟至感染后,而仍能增高存活率。

“PPMO 杀死细菌的作用机理引起了巨大的变革,”第一作者,俄勒冈州立大的微生物学教授 Bruce Geller 说。“他们几乎可以被合成以任何基因为靶点的序列,并以此避免产生抗生素耐药性,并避免产生广谱抗生素相关的负面影响。”

Related Links:
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.